1-3 of 3
Yi-Chang Chang
Close
Sort by
Journal Articles

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

Clinical Trials & Observations
Wen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, Chien-Yuan Chen, Hsin-An Hou, Yuan-Yeh Kuo, Ming-Cheng Lee, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Woei Tsay, Shang-Ju Wu, Shang-Yi Huang, Szu-Chun Hsu, Yao-Chang Chen, Yi-Chang Chang, Yi-Yi Kuo, Kuan-Ting Kuo, Fen-Yu Lee, Ming-Chi Liu, Chia-Wen Liu, Mei-Hsuan Tseng, Chi-Fei Huang, Hwei-Fang Tien
Journal: Blood
Blood (2011) 118 (14): 3803–3810.
https://doi.org/10.1182/blood-2011-02-339747
Published: 2011
Includes: Supplemental data
Journal Articles

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 ( ASXL1 ) mutations

Clinical Trials & Observations
Wen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, Chien-Yuan Chen, Jih-Luh Tang, Ming Yao, Woei Tsay, Bor-Sheng Ko, Shang-Ju Wu, Shang-Yi Huang, Szu-Chun Hsu, Yao-Chang Chen, Yen-Ning Huang, Yi-Chang Chang, Fen-Yu Lee, Min-Chih Liu, Chia-Wen Liu, Mei-Hsuan Tseng, Chi-Fei Huang, Hwei-Fang Tien
Journal: Blood
Blood (2010) 116 (20): 4086–4094.
https://doi.org/10.1182/blood-2010-05-283291
Published: 2010
Includes: Supplemental data
Journal Articles

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation

Clinical Trials & Observations
Wen-Chien Chou, Hsin-An Hou, Chien-Yuan Chen, Jih-Luh Tang, Ming Yao, Woei Tsay, Bor-Shen Ko, Shang-Ju Wu, Shang-Yi Huang, Szu-Chun Hsu, Yao-Chang Chen, Yen-Ning Huang, Yi-Chang Chang, Fen-Yu Lee, Ming-Chi Liu, Chia-Wen Liu, Mei-Hsuan Tseng, Chi-Fei Huang, Hwei-Fang Tien
Journal: Blood
Blood (2010) 115 (14): 2749–2754.
https://doi.org/10.1182/blood-2009-11-253070
Published: 2010
Includes: Supplemental data